The Japanese benchmark index is having another banner year, which culminated to July’s record peak. The central bank’s accommodative stance despite the policy pivot and the Yen’s protracted slump, were the key drivers. But even if slowly, the Bank of Japan is moving towards a less loose setting, after exiting negative rates regime in a historic decision in March. Policymakers have pointed to less bond buying ahead and there are mounting expectations that policymakers will hike again next week.
These prospects help the ailing Yen rebound (along with intervention speculation) and send the JPN225 to correction territory, with a more than 10% slide for the all-time highs. This threatens the pivotal 200Days EMA (blue line) and a breach would open the door to bigger losses towards and beyond 35,771.
However, there is ambivalence around the timing of the next rate increase, while officials have disappointed hawkish expectation in the past and have wrong-footed markets before. Furthermore, the Yen’s demise has made Japanese equities more appealing to foreign investors and ultra-loose monetary policies may have been key drivers of the rally in Japanese equities, but they are not the only culprits. Structural reforms, favorable policies by the government and strong corporate earnings are among the supportive factors.
Furthermore the drop is stretched from a technical perspective, as the RSI reached the most oversold in years. This can help JPN225 stage a comeback as it already defends the 200Days EMA. It may get the opportunity to reclaim the EMA200 (black line) at around the 40K mark. Successful effort would reinstate the bullish bias, but strong catalyst would be needed.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 62% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Stratos Europe Ltd (trading as “FXCM” or “FXCM EU”), previously FXCM EU Ltd (fxcm.com/eu):
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 59% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Trading FX/CFDs carries significant risks. FXCM AU (AFSL 309763). Please read the Financial Services Guide, Product Disclosure Statement, Target Market Determination and Terms of Business at fxcm.com/au
Any opinions, news, research, analyses, prices, other information, or links to third-party sites contained on this video are provided on an "as-is" basis, as general market commentary and do not constitute investment advice. The market commentary has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is therefore not subject to any prohibition on dealing ahead of dissemination. Although this commentary is not produced by an independent source, FXCM takes all sufficient steps to eliminate or prevent any conflicts of interests arising out of the production and dissemination of this communication. The employees of FXCM commit to acting in the clients' best interests and represent their views without misleading, deceiving, or otherwise impairing the clients' ability to make informed investment decisions. For more information about the FXCM's internal organizational and administrative arrangements for the prevention of conflicts, please refer to the Firms' Managing Conflicts Policy. Please ensure that you read and understand our Full Disclaimer and Liability provision concerning the foregoing Information, which can be accessed via FXCM`s website:
Follow and Trade this analysis from your Charts. FXCM now Integrated with TradingView. Contact FXCM for more information.
Also on:
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.